Skip to main navigation
Loading
  • News
  • Investors
  • Careers
  • Contact
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

SEC Filings

  • Overview
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Press Releases
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • IRS – Required Disclosures
  • SEC Filings
    • Quarterly Results
  • Contact
  • Email Alerts
Filing date Form Description Filing Group View
03-16-2016 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001564590-16-014881.rtf
0001564590-16-014881.xls
0001564590-16-014881.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
03-10-2017 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-17-004317.rtf
0001437749-17-004317.xls
0001437749-17-004317.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
03-30-2018 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-18-005932.rtf
0001437749-18-005932.xls
0001437749-18-005932.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
03-01-2019 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-19-003789.rtf
0001437749-19-003789.xls
0001437749-19-003789.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
02-28-2020 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-20-003965.rtf
0001437749-20-003965.xls
0001437749-20-003965.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
03-12-2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-21-005785.rtf
0001437749-21-005785.xls
0001437749-21-005785.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
03-31-2022 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-22-007725.rtf
0001437749-22-007725.xls
0001437749-22-007725.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
03-07-2023 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001437749-23-005703.rtf
0001437749-23-005703.xls
0001437749-23-005703.pdf
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
04-08-2020 10-K/A

Amendment to a previously filed 10-K

Annual Filings
0001437749-20-007335.rtf
0001437749-20-007335.xls
0001437749-20-007335.pdf
View HTML
05-29-2015 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
0001564590-15-004751.rtf
0001564590-15-004751.xls
0001564590-15-004751.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »

Data provided by Kaleidoscope.

  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use

Scroll to top